Expression of Matrix Metalloproteinase-9 Correlates with Poor Prognosis in Human Malignant Fibrous Histiocytoma
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Purpose: 92 kDa matrix metalloproteinase-9 (MMP-9) is believed to play an important role in degrading the matrix and basement membrane, contributing to the invasion and metastasis of malignant solid tumors. However, little is known about its involvement in a malignant fibrous histiocytoma. The aim of this study was to investigate the expression of MMP-9 and to correlate its expression with clinicopathologic parameters in human malignant fibrous histiocytomas. Materials and Methods: Archival tumor tissues from 20 patients with a malignant fibrous histiocytoma were analyzed by immunohistochemistry for the expression of MMP-9. Clinical information was obtained through the computerized retrospective database from the tumor registry. Results: Seventeen of 20 (85%) tumors showed a positive reaction for MMP-9. MMP-9 activity was inversely correlated with patients' survival time (p=.011). There was no significant correlation between the activated MMP-9 expression and all the other clinicopathologic variables. Conclusion: Our data demonstrate that MMP-9 activation is likely to occur in human malignant fibrous histiocytomas. It is also noteworthy that the expression of MMP-9 may aid in predicting patients' poor prognosis.(Cancer Res Treat. 2004;36:384-388)
참고문헌 (25)
- "Sarcomas of soft tissue. In: AbeloffMD, Armitage JO, Lichter AS, Niederhuber JE, eds. ClinicalOncology", pp.2273~2313 (2000), Churchill Livingstones
- "Soft Tissue Tumors" (1995), Mosby
- "Prognostic factors in 227 patients with malignant fibroushistiocytoma", 69, pp.2098~103 (1992)
- "Tumor ofcell interactions with the extracellular matrix during invasionand metastasis", 9, pp.541~73 (1993)
- "Matrix metalloproteinasesand metastasis", 43, pp.42~51 (1999)
- "New molecular targets and biologicaltherapies in sarcomas", 27, pp.317~326 (2001)
- "Interferons inhibittumor necrosis factor-α-mediated matrix metalloproteinase-9activation via interferon regulatory factor-1 binding competitionwith NF-κB", 277, pp.35766~35775 (2002)
- "Matrixmetalloproteinases: biologic activity and clinical implications", 18, pp.1135~1149 (2000)
- "Production ofmatrix metalloproteinase-9 in early stage B-CLL: suppressionby interferons", 16, pp.791~798 (2002)
- "Transcriptional up-regulation of MMP-9 expressionduring spontaneous epithelial to neuroblast phenotypeconversion by SK-N-SH neuroblastoma cells depends upon GT-box and nuclear factorkappaB elements", 10, pp.353~367 (1999)
- "Grading in soft tissue sarcomas-how and why?", 41, pp.236~240 (2002)
- "The expressionof c-myc, bcl-2 and p53 proteins in adenocarcinomas of lung.", 36, pp.146~150 (2002)
- "Expressionof 72 and 92 kDa type IV collagenase in malignant fibroushistiocytomas and dermatofibromas", 69, pp.305~11 (1993)
- "Immunohistochemicalstudy of membrane type-matrix metalloproteinases(MT-MMPs) and matrix metalloproteinase- 2 (MMP-2) in dermatofibromaand malignant fibrous histiocytoma", 28, pp.119~125 (2002)
- "Collagenases and tissue inhibitor of metalloproteinases A functional balance in tissue degradation", 2, pp.70~76 (1996)
- "Pharmacological inhibition of gelatinase B induction andtumor cell invasion", 67, pp.523~531 (1996)
- "Synthetic inhibitors of matrix metalloproteinases.In: Parks WC, Mecham RP, eds. Matrix metalloproteinases", pp.243~256 (1998), Academic Press
- "Inhibition of matrix metalloproteinase-9expression by a ribozyme blocks metastasis in a rat sarcomamodel system", 56, pp.5279~5284 (1996)
- "Hanemaaijer R, Laitinen M. Inhibition of matrixmetalloproteinase-14 in osteosarcoma cells by clodronate", 111, pp.45~52 (2003)
- "Matrix metalloproteinsases astargets for therapy in Kaposi sarcoma", 13, pp.368~373 (2001)
- "Stage-IIB osteosarcomas around the knee .Astudy of MMP-9 in surviving tumour cells", 84, pp.706~711 (2002)
- "Matrixmetalloproteinase-9 (MMP-9) expression in childhood osseousosteosarcoma", 31, pp.471~474 (1998)
- "Expression and localization of92-kDa type IV collagenase", gelatinase B (MMP-9) in humangliomas, 1996, pp.14, 12~18
- "The92-kDa gelatinase B is expressed by advanced stage melanomacells suppression by somatic cell hybridization with earlystage melanoma cells", 55, pp.4174~4781 (1995)
- "Prognostic significance ofmatrix metalloproteinases 2 and 9 in bladder cancer", 20, pp.2009~2013 (2000)
